Skip to main content
. 2013 Oct 19;11(1):139–152. doi: 10.1007/s13311-013-0231-4

Table 2.

Treatment options for dystonia

Medication Mechanism of action
2a) Oral medications
Trihexyphenidyl Anticholinergic
Baclofen GABA-B receptor agonist
Benzodiazepines GABA enhancer
 Lorazepam
 Diazepam
 Clonazepam
Carbidopa-levodopa Metabolic precursor of dopamine
Muscle relaxants
 Cycloben-zaprine Skeletal muscle relaxant
 Metaxalone Skeletal muscle relaxant
 Carisoprodol Skeletal muscle relaxant
 Methocar-bamol Skeletal muscle relaxant
 Orphenadrine Skeletal muscle relaxant
 Chlorzoxa-zone Skeletal muscle relaxant
Sodium oxybate Salt of gamma-hydroxybutyric acid
Tetrabenazine Vesicular monoamine transporter 2 inhibitor. Weak D2 receptor antagonist
Clozapine Dopamine receptor antagonist, mainly D4
Carbamazepine Anticonvulsant, sodium channel inhibitor
Oxcarbazepine Anticonvulsant, sodium channel inhibitor
Zolpidem Non-benzodiazepine hypnotic, affinity for GABA-benzodiazepine subtype receptor BZ1 (ω1)
Pregabalin Calcium channel inhibitor
2b) Non-pharmacologic therapies
Botulinum toxin
 OnabotulinumtoxinA
 AbobotulinumtoxinA
 IncobotulinumtoxinA
 RimabotulinumtoxinB
Surgery
 Deep brain stimulation
 Ablative procedures
 Selective peripheral denervation
 Intrathecal baclofen
 Intraventricular baclofen
 Oculofacial plastic procedures
Other therapies
 Physical therapy
 Braces
 Eyelid crutches
 Dental devices
 Transcranial magnetic stimulation
 Transcranial alternating current stimulation

GABA = gamma aminobutyric acid